Vanguard Capital Management’s X4 Pharmaceuticals XFOR Stock Holding History
Bought
Maintained
Sold
Other funds holding XFOR
SVCM
KCM
Vanguard Capital Management's XFOR Position: Q3 2026 in Review
Vanguard Capital Management reduced its X4 Pharmaceuticals (XFOR) stake by 4.2% in Q3 2026, selling an estimated $609K and leaving 3,558,591 shares worth $10.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2737.
Vanguard Capital Management first reported a position in XFOR in Q1 2026 and has held it in 3 quarters since. The position peaked at $17.4M in Q2 2026. 97 funds tracked by Wall St. Rank hold XFOR as of Q3 2026.
- Vanguard Capital Management held 3,558,591 shares of X4 Pharmaceuticals worth $10.3M as of Q3 2026.
- Vanguard Capital Management sold 157,268 X4 Pharmaceuticals shares in Q3 2026, an estimated $609K.
- X4 Pharmaceuticals made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #2737 holding.
- Vanguard Capital Management first reported a position in X4 Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
- Vanguard Capital Management's X4 Pharmaceuticals position peaked at $17.4M in Q2 2026.
- 97 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.